Paloma Juarez / 3 May 2024

In-vitro Cultured Meat: A Sustainable Future in the Food Industry

In a world that is constantly evolving, the search for sustainable alternatives to meet our food needs has become imperative. One of the most promising advancements in this field is the development of in-vitro cultured meat, a revolutionary technology with the potential to transform the food industry as we know it. At AINIA, we are working along these lines to carry out the production of cultured meat in an efficient and sustainable manner. Let us tell you about it.

Within the realm of in-vitro cultured meat, we at AINIA are engaged in an innovative project called SMARTFARM. In this multidisciplinary project, we are addressing various key areas to carry out the production of cultured meat in an efficient and sustainable way.

One of the fundamental pillars of this project is the establishment of primary cultures and bovine cell lines from animal biopsies. This phase involves the extraction and cultivation of animal cells, with a specific focus on muscle and adipose (fat) tissue. These cells will serve as the basis for the production of cultured meat.

Challenges in the Production of In-Vitro Cultured Meat

3D bioprinting technology plays a crucial role in this project by enabling the recreation of ideal shapes for meat products. Through 3D printing with cultured meat, it is possible to achieve the desired texture and structure of the meat, providing an authentic and satisfying culinary experience.

  • Scaling Up Production: Scaling up production is another vital aspect for the viability of in-vitro cultured meat on a large scale. The implementation of bioreactors enables the increase of cultured meat production in an efficient, controlled, and reproducible manner. This paves the way to meet the growing demand for sustainable meat alternatives in the market.
  • Alternatives to Fetal Bovine Serum: Lastly, a significant challenge in the production of cultured meat is finding alternatives to commonly used fetal bovine serum. In this project, the expression of growth factors is being explored since their incorporation into the culture medium is essential to replace fetal bovine serum. This allows not only a more ethical and sustainable production of cultured meat but also ensures optimal growth and development of cells, thus aligning the technology with the principles of animal welfare and responsible food production.

carne cultivada in vitro

Benefits of In-Vitro Cultured Meat

Within the SMARTFARM project, where we aim to develop in-vitro cultured meat, we foresee benefits that could transform the food industry and contribute to a sustainable and ethical future:

  • Reduces Greenhouse Gas Emissions: This alternative significantly reduces the need for land, water, and greenhouse gas emissions compared to traditional meat production.
  • Promotes Animal Welfare: This innovative approach also promotes animal welfare by eliminating the breeding and slaughtering of animals, addressing ethical concerns and fostering a more compassionate food system.
  • Decreases the Risk of Foodborne Diseases: Additionally, by being produced in controlled and sanitary environments, it considerably decreases the risk of foodborne diseases, thus ensuring a safer and healthier diet for the population.

These combined benefits position in-vitro cultured meat at the forefront of solutions that can improve our world and change the way we perceive and consume meat. We are on the threshold of a transformative shift towards a more conscious and responsible food future.

Regulation: Towards the Approval of Cultured Meat as Novel Food

It is important to mention that one of the key challenges and requirements for the successful commercialisation of in-vitro cultured meat is obtaining approval as Novel Food. The evaluation and approval of Novel Food are crucial to ensure food safety and compliance with quality standards before cultured meat can be marketed in the EU.

This rigorous process allows authorities to assess potential health risks and gives consumers confidence that novel foods meet the established criteria before being introduced to the market. In this regard, Singapore has set a milestone by approving the sale of in-vitro cultured meat, setting a precedent in the adoption of this innovation and paving the way for its global acceptance.

In-Vitro Cultured Meat, a Sustainable Food Alternative

In this context, at AINIA, we are committed to ensuring the safety and viability of in-vitro cultured meat as a sustainable food alternative. In addition to rigorous food quality and safety evaluations, we will focus on closely monitoring all legal aspects related to the production and commercialisation of this innovative technology, thereby ensuring that regulatory requirements are met and its responsible and effective adoption in the market is promoted.

logo IVACE FEDER 2022

Paloma Juarez

Soy investigadora en biotecnología con experiencia internacional en ingeniería genética y el desarrollo de plataformas biológicas para la obtención de moléculas de alto valor. Actualmente trabajo en el liderazgo y gestión de proyectos europeos de I+D+i, con un enfoque en la transferencia de conocimiento, la innovación colaborativa y la conexión entre la investigación científica y su aplicación real en la industria y la sociedad.

News
related

icono izquierdaicono derecha

Do you find this topic interesting?
Contact us

Basic information on data protection

Responsible AINIA
Address Calle Benjamín Franklin, 5 a 11, CP 46980 Paterna (Valencia)
Purpose To attend to, register and contact you to resolve the request you make to us through this contact form
Legitimation Your data will be processed only with your consent, by checking the box shown on this form
Recipients Your data will not be transferred to third parties.
Rights You have the right to request access to, correct or delete your data. You can also request that we limit its processing, oppose it and request the portability of your data by contacting our postal address or [email protected]
More info You can find more information in our Privacy Policy
DPO If you have any questions about how we will treat your data or would like to make any suggestions or complaints, please contact the Data Protection Officer at [email protected] or at the Data subject support form

I consent to the use of my personal data to process my request, as set forth in your Privacy Policy

I consent to the use of my data to receive information and commercial communications from your entity.

Paloma Juarez
Paloma Juárez es doctora en Biotecnología, con formación inicial en Ciencias Biológicas por la Universitat de València y un máster en Biotecnología Molecular y Celular de Plantas por la Universidad Politécnica de Valencia. Su tesis doctoral se centró en la producción de anticuerpos en plataformas vegetales para aplicaciones de inmunoterapia oral pasiva, combinando biotecnología vegetal, expresión recombinante y aplicaciones biomédicas. Tras el doctorado, realizó un primer posdoctorado en Bélgica en el VIB (Plant Systems Biology, Universidad de Gante), financiado mediante una beca posdoctoral FWO belga competitiva, donde trabajó en ingeniería genética de plantas y en el desarrollo de vacunas orales. Posteriormente, obtuvo una beca Marie Skłodowska-Curie de la Comisión Europea, con la que continuó su etapa posdoctoral enfocándose en el diseño de anticuerpos y su producción en plataformas vegetales como complemento alimentario para nutrición animal. Después de una etapa en Grimstad (sur de Noruega) por motivos de reunificación familiar, regresó a Valencia para incorporarse al CSIC como investigadora posdoctoral, donde trabajó en edición genética de plantas. Tras su etapa académica, se incorporó a AINIA, en el departamento de Microbiología y Biotecnología Industrial, donde participó activamente en la creación y consolidación del laboratorio de biología molecular e ingeniería genética, contribuyendo al impulso estratégico de esta línea dentro del centro. Después de cinco años en este departamento, pasó a formar parte de la Unidad de Innovación, donde actualmente ejerce como líder y gestora de proyectos europeos, con un fuerte enfoque en biotecnología, transferencia de tecnología e innovación aplicada.

Suscríbete a nuestra newsletter

Mantente al día de lo más destacado sobre innovación y nuevas tecnologías.
SUSCRIBIRME
close-link